Do analysts recommend SGRY or MCTA?

Surgery Partners presently has a consensus target price of $22.18, suggesting a potential upside of 48.47%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, SGRY or MCTA?

Charming Medical has lower revenue, but higher earnings than Surgery Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surgery Partners $3.31B 0.59 -$77.90M -$0.60 N/A Charming Medical N/A N/A N/A N/A N/A

Does the media refer more to SGRY or MCTA?

In the previous week, Surgery Partners had 1 more articles in the media than Charming Medical. MarketBeat recorded 3 mentions for Surgery Partners and 2 mentions for Charming Medical. Surgery Partners' average media sentiment score of 1.29 beat Charming Medical's score of 0.48 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charming Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer MCTA or ADUS?

Addus HomeCare has a consensus target price of $131.00, suggesting a potential upside of 40.80%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Addus HomeCare 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.70

Which has stronger earnings & valuation, MCTA or ADUS?

Addus HomeCare has higher revenue and earnings than Charming Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Addus HomeCare $1.42B 1.22 $95.91M $5.41 17.20

Which has better earnings and valuation, VRDN or MCTA?

Charming Medical has lower revenue, but higher earnings than Viridian Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Viridian Therapeutics $70.85M 23.48 -$342.60M -$3.32 N/A Charming Medical N/A N/A N/A N/A N/A

Does the media favor VRDN or MCTA?

In the previous week, Viridian Therapeutics had 3 more articles in the media than Charming Medical. MarketBeat recorded 5 mentions for Viridian Therapeutics and 2 mentions for Charming Medical. Charming Medical's average media sentiment score of 0.48 beat Viridian Therapeutics' score of 0.37 indicating that Charming Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viridian Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Charming Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AGL or MCTA?

Agilon Health presently has a consensus target price of $58.73, suggesting a potential downside of 49.10%. Given Agilon Health's stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilon Health 2 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.20 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, AGL or MCTA?

Charming Medical has lower revenue, but higher earnings than Agilon Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilon Health $5.93B 0.32 -$391.35M -$21.56 N/A Charming Medical N/A N/A N/A N/A N/A

Does the media prefer AGL or MCTA?

In the previous week, Agilon Health and Agilon Health both had 2 articles in the media. Agilon Health's average media sentiment score of 0.81 beat Charming Medical's score of 0.48 indicating that Agilon Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charming Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SNDA or MCTA?

Sonida Senior Living presently has a consensus price target of $40.50, suggesting a potential upside of 15.31%. Given Sonida Senior Living's stronger consensus rating and higher probable upside, equities analysts plainly believe Sonida Senior Living is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonida Senior Living 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, SNDA or MCTA?

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonida Senior Living $411.85M 4.04 -$70.78M -$5.83 N/A Charming Medical N/A N/A N/A N/A N/A

Charming Medical (MCTA) Competitors

$29.36 -0.01 (-0.02%)

As of 06/10/2026

Compare

MCTA vs. SGRY, ADUS, VRDN, AGL, and SNDA

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Surgery Partners (SGRY), Addus HomeCare (ADUS), Viridian Therapeutics (VRDN), Agilon Health (AGL), and Sonida Senior Living (SNDA). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Surgery Partners?

Surgery Partners (NASDAQ:SGRY) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

In the previous week, Surgery Partners had 1 more articles in the media than Charming Medical. MarketBeat recorded 3 mentions for Surgery Partners and 2 mentions for Charming Medical. Surgery Partners' average media sentiment score of 1.29 beat Charming Medical's score of 0.48 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Charming Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Surgery Partners presently has a consensus target price of $22.18, suggesting a potential upside of 48.47%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Charming Medical has lower revenue, but higher earnings than Surgery Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.59	-$77.90M	-$0.60	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

Charming Medical has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Charming Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Charming Medical	N/A	N/A	N/A

Summary

Surgery Partners beats Charming Medical on 9 of the 10 factors compared between the two stocks.

How does Charming Medical compare to Addus HomeCare?

Charming Medical (NASDAQ:MCTA) and Addus HomeCare (NASDAQ:ADUS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

In the previous week, Charming Medical had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 2 mentions for Charming Medical and 1 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.87 beat Charming Medical's score of 0.48 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Overall Sentiment
Charming Medical	Neutral
Addus HomeCare	Very Positive

Addus HomeCare has a consensus target price of $131.00, suggesting a potential upside of 40.80%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70

95.4% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Addus HomeCare has a net margin of 6.89% compared to Charming Medical's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Charming Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Addus HomeCare	6.89%	9.80%	7.34%

Addus HomeCare has higher revenue and earnings than Charming Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Addus HomeCare	$1.42B	1.22	$95.91M	$5.41	17.20

Summary

Addus HomeCare beats Charming Medical on 11 of the 12 factors compared between the two stocks.

How does Charming Medical compare to Viridian Therapeutics?

Viridian Therapeutics (NASDAQ:VRDN) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

Charming Medical has lower revenue, but higher earnings than Viridian Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viridian Therapeutics	$70.85M	23.48	-$342.60M	-$3.32	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viridian Therapeutics	-490.31%	-80.19%	-48.84%
Charming Medical	N/A	N/A	N/A

In the previous week, Viridian Therapeutics had 3 more articles in the media than Charming Medical. MarketBeat recorded 5 mentions for Viridian Therapeutics and 2 mentions for Charming Medical. Charming Medical's average media sentiment score of 0.48 beat Viridian Therapeutics' score of 0.37 indicating that Charming Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viridian Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Charming Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Viridian Therapeutics presently has a consensus target price of $36.14, indicating a potential upside of 123.93%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, equities research analysts plainly believe Viridian Therapeutics is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viridian Therapeutics	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Viridian Therapeutics beats Charming Medical on 5 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Agilon Health?

Agilon Health (NYSE:AGL) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

Charming Medical has lower revenue, but higher earnings than Agilon Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.32	-$391.35M	-$21.56	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

Agilon Health presently has a consensus target price of $58.73, suggesting a potential downside of 49.10%. Given Agilon Health's stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Charming Medical has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Charming Medical's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Charming Medical	N/A	N/A	N/A

In the previous week, Agilon Health and Agilon Health both had 2 articles in the media. Agilon Health's average media sentiment score of 0.81 beat Charming Medical's score of 0.48 indicating that Agilon Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Charming Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Agilon Health beats Charming Medical on 5 of the 8 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Charming Medical (NASDAQ:MCTA) are both small-cap services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

87.6% of Sonida Senior Living shares are held by institutional investors. 39.3% of Sonida Senior Living shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonida Senior Living	-24.15%	-36.98%	-7.08%
Charming Medical	N/A	N/A	N/A

In the previous week, Charming Medical had 2 more articles in the media than Sonida Senior Living. MarketBeat recorded 2 mentions for Charming Medical and 0 mentions for Sonida Senior Living. Sonida Senior Living's average media sentiment score of 0.92 beat Charming Medical's score of 0.48 indicating that Sonida Senior Living is being referred to more favorably in the media.

Company	Overall Sentiment
Sonida Senior Living	Positive
Charming Medical	Neutral

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonida Senior Living	$411.85M	4.04	-$70.78M	-$5.83	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

Sonida Senior Living presently has a consensus price target of $40.50, suggesting a potential upside of 15.31%. Given Sonida Senior Living's stronger consensus rating and higher probable upside, equities analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonida Senior Living	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Sonida Senior Living beats Charming Medical on 7 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCTA vs. The Competition

Export

Metric	Charming Medical	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$497.21M	$1.57B	$960.40M	$11.73B
Dividend Yield	N/A	N/A	4.80%	5.56%
P/E Ratio	N/A	15.11	11.17	24.35
Price / Sales	N/A	5.80	47.40	122.29
Price / Cash	N/A	3,057.15	347.14	54.62
Price / Book	N/A	37.40	11.34	6.82
Net Income	N/A	-$26.94M	-$12.37M	$337.41M
7 Day Performance	N/A	1.35%	0.88%	2.49%
1 Month Performance	-0.02%	-2.54%	-6.51%	3.69%
1 Year Performance	N/A	N/A	49.57%	27.72%

Charming Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCTA Charming Medical	N/A	$29.36 0.0%	N/A	N/A	$497.21M	N/A	N/A	49	Gap Down High Trading Volume
SGRY Surgery Partners	3.9332 of 5 stars	$13.96 +0.8%	$22.18 +58.9%	-35.5%	$1.81B	$3.31B	N/A	16,000	Positive News
ADUS Addus HomeCare	4.1107 of 5 stars	$92.70 +2.2%	$131.00 +41.3%	-17.4%	$1.69B	$1.42B	17.13	50,659	Positive News
VRDN Viridian Therapeutics	3.6179 of 5 stars	$16.31 +3.7%	$36.14 +121.6%	+0.3%	$1.62B	$70.85M	N/A	50
AGL Agilon Health	1.633 of 5 stars	$101.74 +6.7%	$58.73 -42.3%	+102.0%	$1.59B	$5.93B	N/A	1,076	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 6/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Charming Medical (MCTA) Competitors

MCTA vs. SGRY, ADUS, VRDN, AGL, and SNDA

How does Charming Medical compare to Surgery Partners?

Summary

How does Charming Medical compare to Addus HomeCare?

Summary

How does Charming Medical compare to Viridian Therapeutics?

Summary

How does Charming Medical compare to Agilon Health?

Summary

How does Charming Medical compare to Sonida Senior Living?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Charming Medical (MCTA) Competitors

MCTA vs. SGRY, ADUS, VRDN, AGL, and SNDA

How does Charming Medical compare to Surgery Partners?

Does the media refer more to SGRY or MCTA?

Do analysts recommend SGRY or MCTA?

Which has stronger earnings & valuation, SGRY or MCTA?

Is SGRY or MCTA more profitable?

Summary

How does Charming Medical compare to Addus HomeCare?

Does the media refer more to MCTA or ADUS?

Do analysts prefer MCTA or ADUS?

Do insiders and institutionals have more ownership in MCTA or ADUS?

Is MCTA or ADUS more profitable?

Which has stronger earnings & valuation, MCTA or ADUS?

Summary

How does Charming Medical compare to Viridian Therapeutics?

Which has better earnings and valuation, VRDN or MCTA?

Is VRDN or MCTA more profitable?

Does the media favor VRDN or MCTA?

Do analysts recommend VRDN or MCTA?

Summary

How does Charming Medical compare to Agilon Health?

Which has stronger valuation and earnings, AGL or MCTA?

Do analysts recommend AGL or MCTA?

Is AGL or MCTA more profitable?

Does the media prefer AGL or MCTA?

Summary

How does Charming Medical compare to Sonida Senior Living?

Do insiders and institutionals have more ownership in SNDA or MCTA?

Is SNDA or MCTA more profitable?

Does the media prefer SNDA or MCTA?

Which has better valuation and earnings, SNDA or MCTA?

Do analysts rate SNDA or MCTA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools